| Genomic prediction of coronary heart disease G Abraham, AS Havulinna, OG Bhalala, SG Byars, AM De Livera, ... European heart journal 37 (43), 3267-3278, 2016 | 372 | 2016 |
| The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation AM Bond, OG Bhalala, JA Kessler Developmental neurobiology 72 (7), 1068-1084, 2012 | 300 | 2012 |
| The emerging roles of microRNAs in CNS injuries OG Bhalala, M Srikanth, JA Kessler Nature Reviews Neurology 9 (6), 328-339, 2013 | 289 | 2013 |
| microRNA-21 regulates astrocytic response following spinal cord injury OG Bhalala, L Pan, V Sahni, TL McGuire, K Gruner, WG Tourtellotte, ... Journal of Neuroscience 32 (50), 17935-17947, 2012 | 254 | 2012 |
| Accurate and robust genomic prediction of celiac disease using statistical learning G Abraham, JA Tye-Din, OG Bhalala, A Kowalczyk, J Zobel, M Inouye PLoS genetics 10 (2), e1004137, 2014 | 126 | 2014 |
| Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissue OG Bhalala, AP Nath, UK Brain Expression Consortium, M Inouye, ... PLoS genetics 14 (8), e1007607, 2018 | 36 | 2018 |
| Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial SB Coutts, S Ankolekar, R Appireddy, JF Arenillas, Z Assis, P Bailey, ... The Lancet 403 (10444), 2597-2605, 2024 | 31 | 2024 |
| Towards a molecular systems model of coronary artery disease G Abraham, OG Bhalala, PIW de Bakker, S Ripatti, M Inouye Current Cardiology Reports 16, 1-10, 2014 | 29 | 2014 |
| Using small molecules to overcome drug resistance induced by a viral oncogene I Smukste, O Bhalala, M Persico, BR Stockwell Cancer Cell 9 (2), 133-146, 2006 | 27 | 2006 |
| The Emerging Impact of microRNAs in Neurotrauma Pathophysiology and Therapy. OG Bhalala Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects., 2015 | 18 | 2015 |
| Rapid and simple tandem mass spectrometry method for determination of serum cotinine concentration MD Kellogg, J Behaderovic, O Bhalala, N Rifai Clinical chemistry 50 (11), 2157-2159, 2004 | 15 | 2004 |
| Generation of Mouse Spinal Cord Injury OG Bhalala, L Pan, H North, T McGuire, JA Kessler Bio Protoc. 3 (17), e886, 2013 | 8 | 2013 |
| Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease OG Bhalala, R Watson, N Yassi International Journal of Molecular Sciences 25 (2), 1231, 2024 | 6 | 2024 |
| Contextualising the benefits and risks of anti‐amyloid therapy for patients with Alzheimer disease and their care team OG Bhalala, J Thompson, R Watson, N Yassi Medical Journal of Australia 221 (2), 78-82, 2024 | 1 | 2024 |
| Multi‐omic blood biomarkers and cognitive profiles discriminate causes of younger‐onset neurocognitive symptoms: a cohort study OG Bhalala, J Beamish, P Summerell, T Porter, SM Laws, M Kang, A Huq, ... Alzheimer's & Dementia 20 (Suppl 2), e085786, 2025 | | 2025 |
| Diagnosis of dysferlinopathy masked by a superimposed hypothyroid myopathy KW Benn, OG Bhalala, TJ Day, CR French BMJ Case Reports CP 17 (8), e260986, 2024 | | 2024 |
| Blood biomarker profiles in young-onset neurocognitive disorders: a cohort study OG Bhalala, J Beamish, D Eratne, P Summerell, T Porter, SM Laws, ... Australian & New Zealand Journal of Psychiatry, 00048674241312805, 2024 | | 2024 |
| 2743 Remission of refractory primary angiitis of the central nervous system with infliximab therapy–a case report OG Bhalala, AL Nguyen BMJ Neurology Open 5 (Suppl 1), 2023 | | 2023 |
